The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Topic summary

Irish differences from the UK position

This is a generated summary. It shows the 9 most-liked posts from a topic of 67, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
K
KAnderssonTL3Regular17 Sep 2024#1

Posting this under the heading it deserves: Irish differences from the UK position Everything below is what sits behind that.

Documenting an access outcome, dated, because everything in this category expires.

As of June 2026, in my region, the position is as described below. I have linked the primary source rather than a summary of it, because the summaries are consistently a year behind.

If anyone can confirm or contradict this for their own region, please date your answer. An undated claim in this category is worse than no claim.

56 likes 22mo
OL
o.lindgrenTL2Regular Solution19 Sep 2024 · edited#2

Supply and shortage resilience: both UK and Ireland sourced primarily from European suppliers until recent disruptions. Domestic availability and pricing changed.

7 likes 22mo
JM
j.mwangiTL4 Moderator26 Sep 2024#10
Staff post. Actions described here are recorded in the public moderation log and may be challenged in Meta.

On post #6 — agreed on the reasoning, with one qualification.

Compounding pharmacies: UK allows compounding under specific conditions when a licensed product is unavailable. That is not a front-line option but becomes relevant during shortages.

31 likes 22mo
EF
e.ferrariTL2 Moderator30 Sep 2024 · edited#15

I read post #13 twice before replying, because I had assumed the opposite.

Private prescribing is legal and widespread, including through remote consultation. Pharmacies must satisfy themselves that a prescription is clinically appropriate. Expect to be asked for measurements and history.

27 likes 22mo
SG
s.grimaldiTL2 Moderator5 Oct 2024#22

NHS access has been restricted by commissioning criteria, not by licensing. Specialist weight-management services in many areas require prior weight-loss attempts, BMI thresholds, or other specific criteria.

32 likes 22mo
RS
r.serranoTL2 Moderator7 Oct 2024#26
a.kowalczyk, post #6: Private prescribing is legal and widespread, including through remote consultation. Pharmacies must satisfy themselves that a prescription is clinically appropriate. Expect to be asked for measurements and history. Go to post

I read post #24 twice before replying, because I had assumed the opposite.

Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing.

The correction was fair and I had been repeating something I had not checked carefully enough.

24 likes in reply to #6 22mo
VK
v.krastevTL2 Moderator14 Oct 2024 · edited#38

NHS access has been restricted by commissioning criteria, not by licensing. Specialist weight-management services in many areas require prior weight-loss attempts, BMI thresholds, or other specific criteria.

30 likes 21mo
DV
d.vukovicTL2 Moderator18 Oct 2024#45

Compounding pharmacies: UK allows compounding under specific conditions when a licensed product is unavailable. That is not a front-line option but becomes relevant during shortages.

26 likes 21mo
MY
m.yilmazTL2 Moderator27 Oct 2024 · edited#61

This follows post #58 rather than contradicting it.

I disagree with the reply above, and I think the disagreement is substantive rather than terminological.

The distinction being drawn does not survive when you look at the published data for this specific question. I would be glad to be shown wrong on this, because the version I am arguing against is more convenient.

25 likes 21mo

Read the full topic (67 posts)

Suggested topics

TopicParticipantsRepliesViewsActivity
Pharmacy supply in the UK and the questions you will be asked
On the subject in the title: Pharmacy supply in the UK and the questions you will be asked Working notes rather than a conclusion. A coverage question with the paperwork detail included, since that is what…
CMCBRMNSP+95 105 1.3k 4mo
NHS criteria and how they are applied in practice
NHS criteria and how they are applied in practice — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is what determines…
AEUCRVTPAV+37 42 31k 2d
UK access routes, dated and sourced
UK access routes, dated and sourced Writing it up because I had to work it out twice and would rather nobody else did. Documenting an access outcome, dated, because everything in this category expires. As of…
NROJC 2 5.8k 15mo
Coming back to: Private prescribing in the UK: what is actually involved
Private prescribing in the UK: what is actually involved Writing it up because I had to work it out twice and would rather nobody else did. A coverage question with the paperwork detail included, since that…
FNFLAWCFKB+62 67 2.1k 6mo
About the UK & Ireland category
MHRA positions, NHS pathways, private prescriptions, and Irish differences. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author and a…
SLHSJVIAK+3 7 357 3mo

Related topics — sharing the tags MHRA, cost per milligram, NHS

TopicParticipantsRepliesViewsActivity
What a regulator's shortage notice actually authorises — what changed since
The question in the title: What a regulator's shortage notice actually authorises — what changed since I will give what I have already checked below so nobody repeats it. A logistics question, since the…
JMMBUCRVW+22 26 53k 7mo
Reading a regulatory notice rather than an article about it — what changed since
Reading a regulatory notice rather than an article about it — what changed since — setting out what I have, and where I think it stops being reliable. A logistics question, since the answers here are usually…
NSJRIBTYCC+28 32 640 13mo
Prescription portability between countries — the long version
On the subject in the title: Prescription portability between countries — the long version Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category…
HVMRSC 2 182 21h
Irish differences from the UK position — what changed since
Irish differences from the UK position — what changed since — setting out what I have, and where I think it stops being reliable. Documenting an access outcome, dated, because everything in this category…
DOFNTIANPM+8 12 782 1d
Labelling requirements for research chemicals
Labelling requirements for research chemicals — setting out what I have, and where I think it stops being reliable. Structured report rather than an opinion, following the format the maintainers asked for.…
BNCGCCMLNN+5 9 45k 4mo